Skip to main content

Published locations for FDA approves ibrutinib as first-line CLL therapy

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves ibrutinib as first-line CLL therapy

User login

  • Reset your password
  • /content/fda-approves-ibrutinib-first-line-cll-therapy
  • /hematology-oncology/article/188407/leukemia-myelodysplasia-transplantation/fda-approves-ibrutinib-first-line
  • /hematologytimes/article/188407/leukemia-myelodysplasia-transplantation/fda-approves-ibrutinib-first